Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C27H26ClF3N6O3 |
Molecular Weight | 574.982 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC(=O)[C@@H](N)CC1=CC=C(C=C1)C2=CC(O[C@H](C3=C(C=C(Cl)C=C3)N4C=CC(C)=N4)C(F)(F)F)=NC(N)=N2
InChI
InChIKey=MDSQOJYHHZBZKA-GBXCKJPGSA-N
InChI=1S/C27H26ClF3N6O3/c1-3-39-25(38)20(32)12-16-4-6-17(7-5-16)21-14-23(35-26(33)34-21)40-24(27(29,30)31)19-9-8-18(28)13-22(19)37-11-10-15(2)36-37/h4-11,13-14,20,24H,3,12,32H2,1-2H3,(H2,33,34,35)/t20-,24+/m0/s1
Molecular Formula | C27H26ClF3N6O3 |
Molecular Weight | 574.982 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 19:47:06 UTC 2023
by
admin
on
Fri Dec 15 19:47:06 UTC 2023
|
Record UNII |
8G388563M7
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C471
Created by
admin on Fri Dec 15 19:47:06 UTC 2023 , Edited by admin on Fri Dec 15 19:47:06 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
Telotristat ethyl
Created by
admin on Fri Dec 15 19:47:06 UTC 2023 , Edited by admin on Fri Dec 15 19:47:06 UTC 2023
|
PRIMARY | |||
|
SUB179123
Created by
admin on Fri Dec 15 19:47:06 UTC 2023 , Edited by admin on Fri Dec 15 19:47:06 UTC 2023
|
PRIMARY | |||
|
DB12095
Created by
admin on Fri Dec 15 19:47:06 UTC 2023 , Edited by admin on Fri Dec 15 19:47:06 UTC 2023
|
PRIMARY | |||
|
CHEMBL2105695
Created by
admin on Fri Dec 15 19:47:06 UTC 2023 , Edited by admin on Fri Dec 15 19:47:06 UTC 2023
|
PRIMARY | |||
|
C150126
Created by
admin on Fri Dec 15 19:47:06 UTC 2023 , Edited by admin on Fri Dec 15 19:47:06 UTC 2023
|
PRIMARY | |||
|
25181577
Created by
admin on Fri Dec 15 19:47:06 UTC 2023 , Edited by admin on Fri Dec 15 19:47:06 UTC 2023
|
PRIMARY | |||
|
DTXSID001102271
Created by
admin on Fri Dec 15 19:47:06 UTC 2023 , Edited by admin on Fri Dec 15 19:47:06 UTC 2023
|
PRIMARY | |||
|
1033805-22-9
Created by
admin on Fri Dec 15 19:47:06 UTC 2023 , Edited by admin on Fri Dec 15 19:47:06 UTC 2023
|
PRIMARY | |||
|
8G388563M7
Created by
admin on Fri Dec 15 19:47:06 UTC 2023 , Edited by admin on Fri Dec 15 19:47:06 UTC 2023
|
PRIMARY | |||
|
EU/3/09/661(POSITIVE)
Created by
admin on Fri Dec 15 19:47:06 UTC 2023 , Edited by admin on Fri Dec 15 19:47:06 UTC 2023
|
PRIMARY | On 30 May 2016, orphan designation (EU/3/09/661) was granted by the European Commission to Ipsen Pharma, France, for (S)-ethyl 2-amino-3-(4-(2-amino-6(-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoate (also known as telotristat etiprate) for the treatment of carcinoid syndrome. | ||
|
5214
Created by
admin on Fri Dec 15 19:47:06 UTC 2023 , Edited by admin on Fri Dec 15 19:47:06 UTC 2023
|
PRIMARY | |||
|
100000164628
Created by
admin on Fri Dec 15 19:47:06 UTC 2023 , Edited by admin on Fri Dec 15 19:47:06 UTC 2023
|
PRIMARY | |||
|
m12015
Created by
admin on Fri Dec 15 19:47:06 UTC 2023 , Edited by admin on Fri Dec 15 19:47:06 UTC 2023
|
PRIMARY | |||
|
1872441
Created by
admin on Fri Dec 15 19:47:06 UTC 2023 , Edited by admin on Fri Dec 15 19:47:06 UTC 2023
|
PRIMARY | |||
|
WW-146
Created by
admin on Fri Dec 15 19:47:06 UTC 2023 , Edited by admin on Fri Dec 15 19:47:06 UTC 2023
|
PRIMARY | |||
|
8G388563M7
Created by
admin on Fri Dec 15 19:47:06 UTC 2023 , Edited by admin on Fri Dec 15 19:47:06 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
TARGET -> INHIBITOR | |||
|
TARGET -> INHIBITOR |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE INACTIVE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |